GUAIFENESIN ![]() (gwye-fen'e-sin) ![]() Anti-Tuss, GG-Cen, Glyceryl Guaiacolate, Glycotuss, Glytuss, Guiatuss, Humibid, Hytuss, Malotuss, Mytussin, Mucinex, Resyl ![]() Classifications: expectorant; Therapeutic: expectorant Pregnancy Category: C |
100 mg/5 mL syrup; 100 mg/5 mL, 200 mg/5 mL liquid; 200 mg capsules; 300 mg sustained release capsules; 100 mg, 200 mg, 1200 mg tablets; 600 mg sustained release tablets
Enhances reflex outflow of respiratory tract fluids by irritation of gastric mucosa.
Aids in expectoration by reducing adhesiveness and surface tension of secretions.
To combat dry, nonproductive cough associated with colds and bronchitis. A common ingredient in cough mixtures.
Hypersensitivity to guaifenesin; pregnancy (category C), lactation. Cough due to CHF, ACE inhibitor therapy, or tobacco smoking.
Chronic cough; asthma; lactation.
Cough Adult: PO 200400 mg q4h up to 2.4 g/d Child: PO <2 y, 12 mg/kg/d in 6 divided doses; 25 y, 50100 mg q4h up to 600 mg/d; 611 y, 100200 mg q4h up to 1.2 g/d |
Guaifenesin may produce color interference with certain laboratory determinations of urinary 5-hydroxyindoleacetic acid (5-HIAA) and vanillylmandelic acid (VMA).
Assessment & Drug Effects
Patient & Family Education